WuXi Biologics (Cayman) Inc (WXIBF)
1.48
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
WuXi Biologics Enterprise Value: 5.398B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 5.398B |
| May 30, 2024 | 5.398B |
| May 29, 2024 | 5.314B |
| May 28, 2024 | 5.314B |
| May 24, 2024 | 6.292B |
| May 23, 2024 | 6.292B |
| May 22, 2024 | 6.292B |
| May 21, 2024 | 6.292B |
| May 20, 2024 | 6.813B |
| May 17, 2024 | 7.645B |
| May 16, 2024 | 7.645B |
| May 15, 2024 | 7.645B |
| May 14, 2024 | 7.645B |
| May 13, 2024 | 7.645B |
| May 10, 2024 | 7.645B |
| May 09, 2024 | 6.022B |
| May 08, 2024 | 6.022B |
| May 07, 2024 | 6.022B |
| May 06, 2024 | 6.024B |
| May 03, 2024 | 6.024B |
| May 02, 2024 | 6.024B |
| May 01, 2024 | 6.022B |
| April 30, 2024 | 6.230B |
| April 29, 2024 | 6.230B |
| April 26, 2024 | 6.230B |
| Date | Value |
|---|---|
| April 25, 2024 | 6.084B |
| April 24, 2024 | 6.084B |
| April 23, 2024 | 6.293B |
| April 22, 2024 | 6.296B |
| April 19, 2024 | 6.298B |
| April 18, 2024 | 6.301B |
| April 17, 2024 | 6.322B |
| April 16, 2024 | 6.322B |
| April 15, 2024 | 6.333B |
| April 12, 2024 | 6.783B |
| April 11, 2024 | 6.783B |
| April 10, 2024 | 6.784B |
| April 09, 2024 | 6.201B |
| April 08, 2024 | 6.201B |
| April 05, 2024 | 6.201B |
| April 04, 2024 | 6.203B |
| April 03, 2024 | 6.203B |
| April 02, 2024 | 6.204B |
| April 01, 2024 | 6.956B |
| March 28, 2024 | 7.165B |
| March 27, 2024 | 6.482B |
| March 26, 2024 | 6.482B |
| March 25, 2024 | 6.753B |
| March 22, 2024 | 6.753B |
| March 21, 2024 | 6.962B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.314B
Minimum
May 28 2024
139.49B
Maximum
Nov 16 2020
33.01B
Average
27.30B
Median
Nov 16 2022
Enterprise Value Benchmarks
| Wuxi AppTec Co Ltd | 11.39B |
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 50.79M |
| Zai Lab Ltd | 1.153B |
Enterprise Value Related Metrics
| Earnings Yield | 7.36% |
| Operating Earnings Yield | 9.76% |
| Normalized Earnings Yield | 7.708 |